Fumed Silica CAS 112945-52-5: Identification, Properties and Safety Data

Published: Source: Silica Raw Materials News Section: Silica Raw Materials

📌 Key Takeaways

  • Topic: Silica Factory: How Silica Is Produced and What to Check During a Factory Audit
  • Keywords:
  • Published: 2026-11-20 11:05:16
  • Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals

Acidic Silica Sol: Properties, Stability and Applications

What Is the Melting Point of Silica? Values for Quartz, Cristobalite and Fused Silica
Liu, Y. et al. Dual-functionalized janus mesoporous silica nanoparticles with active targeting and charge reversal for synergistic tumor-targeting therapy. ACS Appl. Mater. Interfac. 11, 44582-44592 (2019). Post CAS Google Scholar
Nouryon Levasil: Colloidal Silica Product Range and Applications
Silica Supplier Thailand: Market Overview and Sourcing Options
Escriche‐Navarro, B. et al. Mesoporous silica materials as an emerging tool for cancer immunotherapy. Adv. Sci. 9, 2200756 (2022). Article Google Scholar
Hydrophobic Silica Powder: Properties, Water Repellency and Industrial Uses
The unique properties of MSNs make it greatly superior for the construction of multifunctional nanocomposites and drug delivery system. Different therapeutic nanoplatforms obtained through the careful design of MSNs have revealed promising potential in the field of targeted disease therapy. Current applications of MSNs include tumor therapy, 367, 368, 369 anti-infection therapy (bacteria and virus), 370, 371, 372, 373 anti-oxidant/anti-inflammatory therapy (Alzheimer's disease, acute kidney injury, etc.), 374, 375, 376 and metabolic diseases treatment (diabetes, osteoporosis, fatty liver, etc) 377, 378, 379, 380 (Fig. 7 ). In general, the targeted therapeutic characteristics of MSNs can be reflected in the following aspects: (1) Loading chemotherapy drugs or other drugs with toxic side influences, so that they can be released in a controlled manner by MSNs at the targeted sites to prevent their premature release. (2) Selective enrichment at the lesion sites through passive targeting or active targeting, resulting in the higher therapeutic efficacy. (3) Use the MSNs matrix to develop a non-invasive, spatial and temporal controllable targeted therapeutic plan, consequently to overcome the limitations and defects of conventional clinical treatment modalities. To date, the emerging targeted therapeutic modalities developed based on MSNs include dynamic therapy such as photodynamic, sonodynamic and chemodynamic therapies, thermal ablation therapy such as photothermal therapy and magnetic thermotherapy, enzyme-like catalytic therapy, immunotherapy, gene therapy, and others. Meanwhile, the integration of various therapeutic modalities on a single MSNs is expected to enhance the therapeutic efficacy synergistically (Fig. 7 ). In this part, we will discuss MSNs-based therapeutic modalities.

Ultra Pure Silica: What Purity Level You Need and Which Industries Use It

What is silica (SiO₂)?

silicone

What is the difference between fumed silica and precipitated silica?

spherical silica manufacturer

What drives silica raw material prices?

silica manufacturer China Zhao, G., Li, N., Yin, M. & Xu, M. Atorvastatin (ATV)-Loaded lipid bilayer-coated mesoporous silica nanoparticles enhance the therapeutic efficacy of acute kidney injury. J. Biomed. Nanotechnol. 17, 1754-1764 (2021). Article CAS PubMed Google Scholar

Cite this article: Silica Raw Materials News. "Silica Sol Manufacturer: Product Types, Quality Control and How to Choose ." Published 2026-11-20 11:05:16. /news/article.html
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.